Literature DB >> 25053732

Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.

Ana Djordjevic Dikic1, Gabrijela Nikcevic2, Srdjan Raspopovic2, Velibor Jovanovic2, Milorad Tesic3, Branko Beleslin3, Jelena Stepanovic3, Vojislav Giga3, Goran Milasinovic2.   

Abstract

AIMS: The aim of the study was to assess the value of coronary flow reserve (CFR) for predicting improvement of left ventricular function after cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: Study population included 40 patients (mean age 58 ± 9 years) with heart failure (ejection fraction 25, 7 ± 5, 4%) and QRS duration of 158 ± 22 ms, planned for CRT. Before and after CRT implantation, CFR was measured non-invasively during hyperaemia induced with adenosine. Responders were defined by decrease in end-systolic volume ≥15%. Follow-up echocardiography and CFR measurements were obtained after 6 months. At baseline there was no significant difference in left ventricular ejection fraction (LVEF), QRS duration, 6 min walk test distance and coronary flow velocity at rest between responder (n = 26) vs. non-responder group (n = 14, P = ns). Before CRT implantation, responders compared with non-responders, showed a greater increase in coronary flow velocity during hyperaemia, and consequently higher CFR: 2.41 ± 0.60 vs. 1.61 ± 0.45 (P = 0.001). There was significant correlation between CFR before CRT implantation and LVEF after 6 months (r = 0.545, P = 0.001). End-diastolic, end-systolic left ventricular diameter, and CFR before CRT were predictors of LV functional improvement. By multivariate analysis, only CFR before CRT was independent predictor of left ventricular recovery in the follow-up period (P = 0.001).
CONCLUSION: Our results demonstrate that preserved CFR in patients with dilated cardiomyopathy is predictive of left ventricular improvement after CRT implantation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac resynchronization therapy; Coronary flow reserve; Dilated cardiomyopathy

Mesh:

Year:  2014        PMID: 25053732     DOI: 10.1093/ehjci/jeu136

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

1.  Assessment of coronary flow reserve predicts long-term outcome of responders to cardiac resynchronization therapy.

Authors:  Kunio Yufu; Hidekazu Kondo; Tetsuji Shinohara; Yumi Ishii; Seiichiro Yoshimura; Ichitaro Abe; Shotaro Saito; Akira Fukui; Norihiro Okada; Hidefumi Akioka; Yasushi Teshima; Mikiko Nakagawa; Naohiko Takahashi
Journal:  Heart Vessels       Date:  2018-11-27       Impact factor: 2.037

Review 2.  Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.

Authors:  Attila Feher; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

3.  Optimization of cardiac resynchronization therapy based on a cardiac electromechanics-perfusion computational model.

Authors:  Lei Fan; Jenny S Choy; Farshad Raissi; Ghassan S Kassab; Lik Chuan Lee
Journal:  Comput Biol Med       Date:  2021-11-19       Impact factor: 4.589

4.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

5.  Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis.

Authors:  Simon Claridge; Zhong Chen; Tom Jackson; Kalpa De Silva; Jonathan Behar; Manav Sohal; Jessica Webb; Eoin Hyde; Matthew Lumley; Kal Asrress; Rupert Williams; Julian Bostock; Motin Ali; Jaswinder Gill; Mark O'Neill; Reza Razavi; Steve Niederer; Divaka Perera; Christopher Aldo Rinaldi
Journal:  J Am Heart Assoc       Date:  2015-12-17       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.